The American Multi-State Operators (MSOs) component of the vertically integrated munKNEE Pure-Play Pot Stock Index has gone up 42% YTD but lags the +62% performance of the Canadian Licensed Producers (LPs) component YTD but has narrowed the gap slightly so far this week with the MSO index constituents only declining by 8.3% vs. 9.7% for the LP index constituents. This article identifies the MSO winners and losers so far this week and the reasons behind their movements.

(For more information on the reason(s) behind the changes outlined below you are urged to click on the stock symbols provided by TalkMarkets, where additional information is provided. All currency amounts are in U.S. dollars. Go here to convert to another currency.)

MSO Pure-Play Pot Stock Index Performance

The criteria for being included in the munKNEE MSO Pure-Play Pot Stock Sub-Index is that the constituents are Multi-State Operators that consistently trade for a minimum of US$1/share and generate 100% of their revenue directly from the sale of cannabis products.

All 21 constituents in the sub-index have declined so far this week with the following 14 stocks declining by 5% or more in descending order:

1. HempFusion (CBDHF): -18.5% to $2.20/share
   • announced the launch of certain Probulin Probiotics products in China to be sold on Alibaba Group Holding’s Tmall Global
2. Vireo Health (VREOF): -13.4% to $2.45/share
   • no noteworthy news
3. Ayr Wellness (AYRWF): -13.2% to $30.74/share
   • announced it has closed on the purchase of Blue Camo LLC, which operates under the name Oasis, a vertically integrated operation in Arizona that includes three medical and adult-use dispensaries in the greater Phoenix area, a 10,000 sq. ft. triple-stacked cultivation and processing facility in Chandler, and an 86,000 sq. ft. cultivation facility under development in Phoenix.
4. Columbia (CCHWF): -11.5% to $5.90/share
   • no noteworthy news
5. Verano (VRNOF): -11.2% to $18.30/share
   • no noteworthy news
6. Charlotte's Web (CWBHF): -10.3% to $4.42/share
   • reported that the clinical results of a Validcare study conducted with 11 other companies over the past seven months reaffirms the safety of Charlotte's Web hemp-derived CBD extracts on liver toxicity
7. Jushi (JUSHF): -9.4% to $6.54/share
   • no noteworthy news
8. Green Thumb (GTBIF): -9.0% to $31.40/share
   • no noteworthy news
9. Acreage (ACRDF; ACRHF): -8.5% to $8.41 on average for both shares
   • no noteworthy news
10. TerrAscend (TRSSF): -8.2% to $10.36/share
    • reported Q4 financial reports (see here)
    • announced that Jason Ackerman stepped down from his role as CEO and Executive Chairman of the Company effective March 23  
11. cbdMD (YCBD): -7.8% to $3.77/share
    • no noteworthy news
12. Planet 13 (PLNHF): -7.1% to $6.11/share
    • announced that it plans to release its Q4 financial results for the fourth quarter and FY2020 on April 5^th, 2021 aftermarket.
13. Curaleaf (CURLF): -6.5% to $15.05/share
    • launched Select Squeeze, a fast-acting THC-infused beverage enhancer featuring Nano-emulsification technology. 
14. Medicine Man (SHWZ): -5.2% to $2.17/share
    • no noteworthy news

The remaining 7 constituents, Lowell Farms (LOWLF), C21 Investments (CXXIF), Trulieve (TCNNF), Harborside (HBORF), IM Cannabis (IMCNF), Cresco (CRLBF), and Harvest Health (HRVSF) have also declined so far this week but by less than 5%.